XM does not provide services to residents of the United States of America.

India's LIC posts Q2 profit fall on higher benefits paid but margin expands



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-India's LIC posts Q2 profit fall on higher benefits paid but margin expands</title></head><body>

Adds details on net premium income, margins paragraph 3 onwards

Nov 8 (Reuters) -Life Insurance Corporation of India (LIC) LIFI.NS, the country's biggest insurer, posted a 3.8% fall in second-quarter profit on Friday as it paid out higher benefits, while new business margins for the half-year expanded.

LIC's profit after tax fell to 76.21 billion rupees ($903.6 million) for the quarter ended Sept. 30 from 79.25 billion rupees a year earlier.

The net premium income rose 11.6% to 1.20 trillion rupees but the net benefits paid by the insurer to policyholders climbed 17% to 975.62 billion rupees during the quarter.

Rising awareness about insurance policies after the COVID-19 pandemic and new product launches have aided net premium income growth for insurers, analysts said.

Solvency ratio, the measure of an insurer's ability to meet its long-term debt obligations, rose to 1.98 during the quarter from 1.90 a year earlier.

LIC has been focusing on increasing its share of high-margin non-participating policies to cushion its margins.

Its net value of new business (VNB), which measures expected profit from new premiums, jumped 37.7% year-over-year for the April-September period. The VNB margin for the period rose to 16.2% from 14.6% a year ago.

Other Indian life insurers such as ICICI Prudential Life Insurance ICIR.NS and HDFC Life Insurance HDFL.NS have struggled to keep their margins intact for the past few quarters with rising demand for low-margin market-linked policies.

LIC's group business' total premium rose 25.4% year-on-year for the April-September period, the insurer said in an exchange filing.

Group insurance covers multiple people in the same plan and is generally taken by companies to provide insurance cover for their employees.

Shares of the company ended 1.6% lower ahead of results.

($1 = 84.3400 Indian rupees)



Reporting by Dimpal Gulwani; Editing by Eileen Soreng

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.